title: Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.
authors.forename: Michael
authors.initials: M
authors.lastname: Steurer
authors.forename: Johannes
authors.initials: J
authors.lastname: Clausen
authors.forename: Thaddaeus
authors.initials: T
authors.lastname: Gotwald
authors.forename: Eberhard
authors.initials: E
authors.lastname: Gunsilius
authors.forename: Guenther
authors.initials: G
authors.lastname: Stockhammer
authors.forename: Guenther
authors.initials: G
authors.lastname: Gastl
authors.forename: David
authors.initials: D
authors.lastname: Nachbaur
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology* / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008297:Male; D000069283:Rituximab; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab